The Rundown Apple Charms Trump with Extra $100B U.S. Investment, Eli Lilly's New Obesity Pill Underwhelms
18 snips
Aug 7, 2025 A prominent CEO charms the White House, gaining a crucial tariff exemption that could reshape U.S. manufacturing. Eli Lilly's new weight loss pill disappoints, contrasting with DoorDash's stock surge. Meanwhile, Airbnb faces challenges, and Intel's stock falters amid political scrutiny over ties to the Chinese military. The discussion wraps up on a light note, highlighting a lavish private island listing once owned by a magician.
AI Snips
Chapters
Transcript
Episode notes
Apple Wins Big Tariff Exemption
- Apple secured a major tariff exemption by committing an additional $100 billion to U.S. investments. - They focus on domestic chip and glass production but won’t mass manufacture products in the US.
Eli Lilly’s Weight Loss Pill Disappoints
- Despite strong sales growth for Eli Lilly’s weight loss drugs, their new obesity pill disappointed investors. - The pill showed less weight loss and higher dropout rates versus competitors' injections.
DoorDash Profits After Growth Surge
- DoorDash’s strong earnings show continued growth in food delivery demand. - They turned a profit after losses, with revenue and order volume surging 20-25%.